ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:1138. doi:10.1016/j.athoracsur.2008.06.004
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Donald E. Low
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Low, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Low, D. E.
Related Collections
Right arrow Esophagus - cancer
Right arrowRelated Article

Original Articles: General Thoracic

Invited Commentary

Donald E. Low, MD

Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, 1100 Ninth Ave, Seattle, WA 98111

(Email: gtsdel@vmmc.org).

The first 20% of the full text of this article appears below.

The article by Roedl and colleagues [1] is a critical assessment using positron emission tomography (PET) and PET computed tomographic (CT) scan to quantify treatment response after neoadjuvant chemoradiotherapy, as well as local and systemic recurrence after definitive treatment. Both of these issues are important, and the authors have provided a new technique for gauging response to neoadjuvant therapy. The article suffers from two technical issues. The first being the fact that pathologic response (assessed as less than 10% remaining viable tumor cells) was not done by a designated subset of pathologists. More importantly, the second of three PET assessments, this one examining response of tumor length, was carried at a mean of 14 days . . . [Full Text of this Article]


Related Article

Assessment of Treatment Response and Recurrence in Esophageal Carcinoma Based on Tumor Length and Standardized Uptake Value on Positron Emission Tomography–Computed Tomography
Johannes B. Roedl, Mukesh G. Harisinghani, Rivka R. Colen, Alan J. Fischman, Michael A. Blake, Douglas J. Mathisen, and Peter R. Mueller
Ann. Thorac. Surg. 2008 86: 1131-1138. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.